Bicyclic inhibitors of factor Xa
US6878710B2 · kind B2 · utility
1Cited by
0References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2002 |
| Grant date | Apr 12, 2005 |
| Priority date | — |
| Expiry date | Jan 4, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates generally to a novel class of bicyclic heterocyclic compounds of the Formula (I): or pharmaceutically acceptable salt forms thereof, which are inhibitors of trypsin-like serine protease enzymes, especially factor Xa, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention of thromboembolic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.